Tag - kobayashi-pharmaceutical

 
 

KOBAYASHI PHARMACEUTICAL

An official of Kobayashi Pharmaceutical speaks to reporters on Saturday in Osaka following the health ministry's inspections of the firm's plant.
JAPAN / Society
Apr 3, 2024
166 hospitalized over health issues linked to beni kōji
Taiwan's health ministry said the number of people experiencing ill health after taking Kobayashi Pharmaceutical's beni koji had risen to 11 as of Monday.
Kobayashi Pharmaceutical's Tokyo office. The company reported more cases of hospitalization linked to its dietary supplements.
JAPAN / Science & Health
Apr 2, 2024
Kobayashi Pharma's health supplements tied to 157 hospitalizations
The figure reflects an increase from the 114 hospitalization cases that the company said were linked to its products containing red yeast rice.
Beni kо̄ji has been widely used in Japan and elsewhere as a food additive, and features prominently in Okinawan cuisine, particularly in a dish called tо̄fuyо̄.
JAPAN / Society
Apr 1, 2024
Beni kōji purveyors fear growing aversion following supplement scandal
The ingredient has long been used in Japan and elsewhere as a food additive, and features prominently in Okinawan cuisine.
Officials from the health ministry arrive at Kobayashi Pharmaceutical's plant in Kinokawa, Wakayama Prefecture, on Sunday for inspection.
JAPAN / Science & Health
Mar 31, 2024
Kobayashi Pharma plants inspected over health problems
The company said five people have died after taking the supplement so far, with the total number of hospitalized users reaching 114.
Kobayashi Pharmaceutical President Akihiro Kobayashi (second from left) and other executives apologize for the deaths and other health damage associated with its dietary supplements, in the city of Osaka on Friday.
JAPAN / Science & Health
Mar 29, 2024
Kobayashi Pharma says blue mold compound may be cause of health problems
The beni kо̄ji red yeast rice dietary supplements are now linked to five deaths and 114 hospitalizations.
Packs of dietary supplements designated as functional food by Kobayashi Pharmaceutical. Consumer rights groups have for years argued that the functional food label is thin in scientific evidence and potentially harmful to health.
JAPAN / Science & Health
Mar 29, 2024
Kobayashi Pharma scandal reignites debate on ‘functional food’ labels
The labels have been criticized for years over the lack of sufficient scientific proof of safety and efficacy accompanying their use.
According to Yano Research Institute, Japan's supplements market grew about 30% in the span of three years.
BUSINESS
Mar 29, 2024
Supplements market in Japan showing steady growth
Improved health awareness sparked by COVID-19 is a major factor fueling the growth, market research firms say.
Kobayashi Pharmaceutical's Osaka manufacturing facility in the city of Osaka on Wednesday
JAPAN / Science & Health / EXPLAINER
Mar 28, 2024
What we know so far about Kobayashi Pharma's supplement deaths
The Osaka-based drugmaker is finding itself under further scrutiny as the search to pinpoint the cause of the deaths continues.
Kobayashi Pharmaceutical holds its annual shareholders meeting on Thursday in Osaka.
JAPAN / Science & Health
Mar 28, 2024
Two more deaths linked to Kobayashi Pharma's red yeast supplements
The company has voluntarily recalled five of its products, including about 300,000 packages of its Beni Koji Choleste Help supplements.
Kobayashi Pharmaceutical has announced a recall of its products.
JAPAN / Science & Health
Mar 27, 2024
Concerns mount after two deaths linked to Kobayashi Pharma supplement
A government probe is being conducted to establish whether the supplement, which contains beni kо̄ji red fermented rice, led to the deaths.
Kobayashi Pharmaceutical is voluntarily recalling products containing beni kōji, including Beni Koji Choleste Help supplements.
JAPAN / Science & Health
Mar 26, 2024
One dead after consuming Kobayashi Pharma's health supplements
The Osaka-based drugmaker is probing the incident to determine any causal link between the product's consumption and the individual's death.
Akihiro Kobayashi (left), president of major drugmaker Kobayashi Pharmaceutical, speaks to reporters along with other executives in Osaka on Friday.
JAPAN / Science & Health
Mar 24, 2024
Osaka drugmaker recalls dietary supplements linked to kidney disorders
The Osaka-based drugmaker announced Friday that, of the six hospitalized, two suffered symptoms serious enough to require temporary dialysis.

Longform

A store clerk tries to cool things down in front of their shop by spraying a hose.
Is extreme weather changing the way Japan shops?